GHTI Stock Overview
Develops products for addressing factors, which cause aging and deterioration in the body. More details
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
G-H-3 International Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$0.000001 |
52 Week High | US$0.000001 |
52 Week Low | US$0.000001 |
Beta | 0 |
11 Month Change | 0% |
3 Month Change | n/a |
1 Year Change | n/a |
33 Year Change | -99.00% |
5 Year Change | -99.00% |
Change since IPO | -100.00% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
GHTI | US Pharmaceuticals | US Market | |
---|---|---|---|
7D | 0% | -7.0% | -2.1% |
1Y | n/a | 8.5% | 29.7% |
Return vs Industry: Insufficient data to determine how GHTI performed against the US Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how GHTI performed against the US Market.
Price Volatility
GHTI volatility | |
---|---|
GHTI Average Weekly Movement | n/a |
Pharmaceuticals Industry Average Movement | 9.7% |
Market Average Movement | 6.2% |
10% most volatile stocks in US Market | 15.6% |
10% least volatile stocks in US Market | 3.1% |
Stable Share Price: GHTI has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine GHTI's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | n/a | Flo Ternes | n/a |
G-H-3 International Inc. develops products for addressing factors, which cause aging and deterioration in the body. Its product, G-H-3-Plus is a comprehensive protocol that promotes anti-aging, treat chronic disease, and improve health and vitality. The G-H-3-Plus protocol includes a combination of intravenous treatment, intramuscular injections, prescriptions, vitamins, and skin care products.
G-H-3 International Inc. Fundamentals Summary
GHTI fundamental statistics | |
---|---|
Market cap | n/a |
Earnings (TTM) | US$0 |
Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs GHTI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
GHTI income statement (TTM) | |
---|---|
Revenue | US$0 |
Cost of Revenue | US$0 |
Gross Profit | US$0 |
Other Expenses | US$0 |
Earnings | US$0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did GHTI perform over the long term?
See historical performance and comparison